Posts by Chad Landmon
In most respects, the widely reported patent complaint recently filed against Gilead is perfectly ordinary. It was filed in the U.S. District Court for the District …
is a partner at Axinn, Veltrop & Harkrider, LLP, where he Chairs the firm’s Intellectual Property and FDA Practice Groups and regularly works with companies developing drugs, biologics, and regenerative medicine and human tissue products.
For more information or to contact Chad, please visit his Firm Profile Page.